These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

945 related articles for article (PubMed ID: 24102636)

  • 1. Insights into direct nose to brain delivery: current status and future perspective.
    Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal delivery of biologics to the central nervous system.
    Lochhead JJ; Thorne RG
    Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal drug delivery to the central nervous system: present status and future outlook.
    Tayebati SK; Nwankwo IE; Amenta F
    Curr Pharm Des; 2013; 19(3):510-26. PubMed ID: 23116337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nose-to-Brain Delivery: Investigation of the Transport of Nanoparticles with Different Surface Characteristics and Sizes in Excised Porcine Olfactory Epithelium.
    Mistry A; Stolnik S; Illum L
    Mol Pharm; 2015 Aug; 12(8):2755-66. PubMed ID: 25997083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving brain drug targeting through exploitation of the nose-to-brain route: a physiological and pharmacokinetic perspective.
    Badhan RK; Kaur M; Lungare S; Obuobi S
    Curr Drug Deliv; 2014; 11(4):458-71. PubMed ID: 24655046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
    Pardeshi CV; Belgamwar VS
    Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
    Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
    Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development.
    Wen MM
    Discov Med; 2011 Jun; 11(61):497-503. PubMed ID: 21712015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal therapeutic strategies for management of Alzheimer's disease.
    Sood S; Jain K; Gowthamarajan K
    J Drug Target; 2014 May; 22(4):279-94. PubMed ID: 24404923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is nose-to-brain transport of drugs in man a reality?
    Illum L
    J Pharm Pharmacol; 2004 Jan; 56(1):3-17. PubMed ID: 14979996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery.
    Dong J; Shang Y; Inthavong K; Chan HK; Tu J
    Pharm Res; 2017 Dec; 35(1):5. PubMed ID: 29288465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
    Md S; Mustafa G; Baboota S; Ali J
    Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
    Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
    Kanazawa T
    Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal delivery to the central nervous system: mechanisms and experimental considerations.
    Dhuria SV; Hanson LR; Frey WH
    J Pharm Sci; 2010 Apr; 99(4):1654-73. PubMed ID: 19877171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal delivery of neuropeptides.
    Veronesi MC; Kubek DJ; Kubek MJ
    Methods Mol Biol; 2011; 789():303-12. PubMed ID: 21922417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct transport of VEGF from the nasal cavity to brain.
    Yang JP; Liu HJ; Cheng SM; Wang ZL; Cheng X; Yu HX; Liu XF
    Neurosci Lett; 2009 Jan; 449(2):108-11. PubMed ID: 18996442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics.
    Bourganis V; Kammona O; Alexopoulos A; Kiparissides C
    Eur J Pharm Biopharm; 2018 Jul; 128():337-362. PubMed ID: 29733950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration.
    Kadakia E; Bottino D; Amiji M
    Pharm Res; 2019 Mar; 36(5):75. PubMed ID: 30923914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.